Literature DB >> 18391675

ANCA vasculitis in the elderly.

Deana D Hoganson1, Aaron M From, Clement J Michet.   

Abstract

BACKGROUND: In population-based estimates of disease, the incidence of ANCA-associated vasculitides is increasing, with the peak age of onset in middle aged and older adults. Clinical characteristics of the very elderly have not been fully elucidated.
METHODS: Patients who met the criteria for Wegener granulomatosis and microscopic polyangiitis were included in the study. The following characteristics were analyzed by retrospective review: time interval from first symptoms to date of diagnosis, age at diagnosis, laboratory values on initial presentation, and Birmingham Vasculitis Activity Score when diagnosed.
RESULTS: Patients >75 years old were more often female, had fewer ear, nose, or throat symptoms, and had lower hemoglobin values. At date of latest follow-up, 40% of the older patients died compared with 11% of the younger cohort (P = 0.0006). Of the deceased elderly patients, nearly one-half died within 6 months. Age >75 carried an elevated risk of mortality (hazard ratio = 2.69, 95% confidence interval = 1.55-4.96; P = 0.0005) as did elevated serum creatinine (hazard ratio = 1.25 per 1 mg/dL, 95% confidence interval = 1.06-1.43; P = 0.0109). Survival was worse in those presenting with Birmingham Vasculitis Activity Score >20 and those >75-year-old.
CONCLUSION: The clinical presentation of ANCA-associated vasculitis is relatively similar among elderly and younger patients. In patients aged 75 years or older, ANCA vasculitis is associated with higher mortality, and related to the presence of renal involvement. Elderly patients have a greater risk for death within the first 6 months after diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18391675     DOI: 10.1097/RHU.0b013e31816b2fbd

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  13 in total

1.  Clinical outcomes of ANCA-associated vasculitis in elderly patients.

Authors:  Ágnes Haris; Kálmán Polner; József Arányi; Henrik Braunitzer; Ilona Kaszás; István Mucsi
Journal:  Int Urol Nephrol       Date:  2014-04-23       Impact factor: 2.370

Review 2.  Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management.

Authors:  Alvise Berti; Roberto Caporali; Carlomaurizio Montecucco; Giuseppe Paolazzi; Sara Monti
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

3.  Outcome and treatment of elderly patients with ANCA-associated vasculitis.

Authors:  Maria Weiner; Su Mein Goh; Aladdin J Mohammad; Zdenka Hruskova; Anisha Tanna; Annette Bruchfeld; Daina Selga; Zdenka Chocova; Kerstin Westman; Per Eriksson; Charles D Pusey; Vladimir Tesar; Alan D Salama; Mårten Segelmark
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-22       Impact factor: 8.237

4.  Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.

Authors:  H Timlin; S M Lee; R L Manno; P Seo; Duvura Geetha
Journal:  Semin Arthritis Rheum       Date:  2015-02-20       Impact factor: 5.532

5.  Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.

Authors:  C Pagnoux; S Carette; N A Khalidi; M Walsh; T F Hiemstra; D Cuthbertson; C Langford; G Hoffman; C L Koening; P A Monach; L Moreland; L Mouthon; P Seo; U Specks; S Ytterberg; K Westman; P Hoglund; L Harper; O Flossman; R Luqmani; C O Savage; N Rasmussen; K de Groot; V Tesar; D Jayne; P A Merkel; L Guillevin
Journal:  Clin Exp Rheumatol       Date:  2015-05-26       Impact factor: 4.473

6.  Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study.

Authors:  Claudius Speer; Christine Altenmüller-Walther; Jan Splitthoff; Christian Nusshag; Florian Kälble; Paula Reichel; Christian Morath; Martin Zeier; Raoul Bergner; Matthias Schaier
Journal:  Medicine (Baltimore)       Date:  2021-07-23       Impact factor: 1.817

7.  The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.

Authors:  Alvise Berti; Divi Cornec; Cynthia S Crowson; Ulrich Specks; Eric L Matteson
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

8.  ANCA and IgA glomerulonephritis all in one: prognosis and complications.

Authors:  Pitchaphon Nissaisorakarn; Vivette D'Agati; Kisra Anis; Belinda Jim
Journal:  BMJ Case Rep       Date:  2017-10-09

9.  Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.

Authors:  Koichi Yamaguchi; Aya Yamaguchi; Miki Itai; Yuji Onuki; Yuki Shin; Shogo Uno; Chiharu Hanazato; Kohei Taguchi; Kazue Umetsu; Masaki Aikawa; Shunichi Kouno; Masao Takemura; Kenichiro Hara; Shinsuke Motegi; Mayuko Tsukida; Fumie Ota; Yoshito Tsukada; Mitsuru Motegi; Masao Nakasatomi; Toru Sakairi; Hidekazu Ikeuchi; Yoriaki Kaneko; Keiju Hiromura; Toshitaka Maeno
Journal:  Rheumatol Int       Date:  2021-05-30       Impact factor: 2.631

10.  Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Byung-Woo Yoo; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Korean J Intern Med       Date:  2020-08-20       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.